Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | MSX-122 |
Synonyms | |
Therapy Description |
MSX-122 is a CXCR4 antagonist, which inhibits SDF-1(CXCL12)-CXCR4 mediated signaling and may inhibit tumor cell metastasis (PMID: 22485156, PMID: 24244561). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MSX-122 | Q 122|Q-122|Q122 | CXCR4 Inhibitor 15 | MSX-122 is a CXCR4 antagonist, which inhibits SDF-1(CXCL12)-CXCR4 mediated signaling and may inhibit tumor cell metastasis (PMID: 22485156, PMID: 24244561). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|